Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Experimental Cell Research|January 22, 2016
Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesisPengfei Li, Youming Guo, Grant Bledsoe, et al.
Immunology|January 29, 2014
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsisPengfei Li, Grant Bledsoe, Zhi-Rong Yang, et al.
Biological Chemistry|February 26, 2010
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healingJulie Chao, Bo Shen, Lin Gao, et al.
Experimental Cell Research|July 10, 2015
Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expressionYouming Guo, Pengfei Li, Grant Bledsoe, et al.
Human Gene Therapy|May 24, 2006
Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene deliveryGrant Bledsoe, Bo Shen, Yuyu Yao, et al.
American Journal of Physiology. Renal Physiology|October 3, 2008
Intermedin ameliorates vascular and renal injury by inhibition of oxidative stressMakoto Hagiwara, Grant Bledsoe, Zhi-Rong Yang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2006
Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosisGrant Bledsoe, Sarah Crickman, Jenny Mao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 24, 2010
Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signalingBo Shen, Lin Gao, Yi-Te Hsu, et al.
Critical Care (London, England)|May 2, 2015
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsisPengfei Li, Youming Guo, Grant Bledsoe, et al.
American Journal of Physiology. Renal Physiology|January 22, 2010
Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradationYuying Liu, Grant Bledsoe, Makato Hagiwara, et al.
Pageof 17